Pharmacologic treatment options for prediabetes

被引：0
|
作者：
Hsueh, Willa A. [1 ,2 ]
Handelsman, Yehuda [3 ]
机构：
[1] Methodist Hosp, Res Inst, Diabet Res Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, Res Inst, Div Diabet Obes & Lipids, Houston, TX 77030 USA
[3] Metab Inst Amer, Tarzana, CA USA
来源：
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM | 2008年 / 4卷 / 07期
关键词：
D O I：
10.1038/ncpendmet0842
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Identification and subsequent treatment of individuals with prediabetes can prevent progression to type 2 diabetes mellitus. Although lifestyle changes are critical in this setting, the question of whether pharmacotherapy should also be used remains unanswered. The authors of this Viewpoint, therefore, discuss potential strategies for pharmacologic intervention.
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
12345